期刊文献+

补充鱼油对慢性心力衰竭防治作用的研究进展 被引量:3

下载PDF
导出
摘要 近年来,尽管慢性心力衰竭(chronic heart failure,CHF)的药物和器械治疗均有了长足的发展,但其患病率、致残致死率依然居高不下[1].因此,在目前指南推荐的最佳药物治疗的基础上,进一步开发和研制可改善CHF患者预后、缓解其临床症状的新型治疗手段,具有十分重要的意义.流行病学研究表明,深海鱼油对多种心血管疾病具有潜在防治作用[2].鱼油的主要成分是长链omega-3多不饱和脂肪酸(omega-3 polyunsaturated fatty acids,n-3 PUFAs),包括二十碳五烯酸(eicosapentaenoic acid,EPA)和二十二碳六烯酸(docosahexaenoic acid,DHA).
作者 辛伟 米树华
出处 《心肺血管病杂志》 CAS 2015年第1期73-75,共3页 Journal of Cardiovascular and Pulmonary Diseases
  • 相关文献

参考文献28

  • 1Go AS,Mozaffarian D,Roger VL,et al.Heart disease and stroke statistics-2013 update:a report from the American Heart Association.Circulation,2013,127:e6-e245.
  • 2De Caterina R.n-3 fatty acids in cardiovascular disease.N Engl J Med,2011,364:2439-2450.
  • 3Djousse L,Akinkuolie AO,Wu JH,et al.Fish consumption,omega-3 fatty acids and risk of heart failure:a meta-analysis.Clin Nutr,2012,31:846-853.
  • 4Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction:results of the GISSI-Prevenzione trial.Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.Lancet,1999,354:447-455.
  • 5Macchia A,Levantesi G,Franzosi MG,et al.Left ventricular systolic dysfunction,total mortality,and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.Eur J Heart Fail,2005,7:904-909.
  • 6Tavazzi L,Maggioni AP,Marchioli R,et al.Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure(the GISSI-HF trial):a randomised,double-blind,placebo-controlled trial.Lancet,2008,372:1223-1230.
  • 7Mc Murray JJ,Adamopoulos S,Anker SD,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2012:The Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the european society of cardiology.Developed in collaboration with the heart failure association(HFA)of the ESC.Eur Heart J,2012,33:1787-1847.
  • 8Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA Guideline for the Management of Heart Failure:Executive Summary:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Circulation,2013.
  • 9Braunwald E,Bristow MR.Congestive heart failure:fifty years of progress.Circulation,2000,102:IV14-23.
  • 10Xin W,Wei W,Li X.Effects of fish oil supplementation on cardiac function in chronic heart failure:a meta-analysis of randomised controlled trials.Heart,2012,98:1620-1625.

二级参考文献33

  • 1刘双,高伟.脓毒症的诊断与治疗[J].心肺血管病杂志,2005,24(2):120-121. 被引量:6
  • 2Dellinger RP,Levy MM,Carlet JM,et al.Surviving Sepsis Cam-paign:international guidelines for management of severe sepsisand septic shock:2008.Intensive Care Med,2008,34:17-60.
  • 3Fernandes CJ,de Assuncao MS.Myocardial dysfunction in sep-sis:a large,unsolved puzzle.Crit Care Res Pract,2012.
  • 4Stengl M,Prucha M,Matejovic M.Cytokines,Heart and CalciumCurrent in Sepsis//Kamkin A,Kiseleva I.Mechanical stretch andcytokines.Springer Netherlands,2012:87-106.
  • 5Flierl MA,Rittirsch D,Huber-Lang MS,et al.Molecular eventsin the cardiomyopathy of sepsis.Mol Med,2008,14:327-336.
  • 6Merx MW,Weber C.Sepsis and the heart.Circulation,2007,116:793-802.
  • 7Carlson DL,Willis MS,White DJ,et al.Tumor necrosis factor-α-induced caspase activation mediates endotoxin-related cardiacdysfunction.Crit Care Med,2005,33:1021-1028.
  • 8Duncan DJ,Yang Z,Hopkins PM,et al.TNF-αand IL-1βin-crease Ca2+leak from the sarcoplasmic reticulum and susceptibil-ity to arrhythmia in rat ventricular myocytes.Cell Calcium,2010,47:378-386.
  • 9Ao L,Song Y,Fullerton DA,et al.The interaction between myo-cardial depressant factors in endotoxemic cardiac dysfunction:Role of TNF-αin TLR4-mediated ICAM-1 expression.Cytokine,2007,38:124-129.
  • 10Kumar A,Parrillo JE.Myocardial Depression in Sepsis and SepticShock//Abraham E,Singer M.Mechanisms of Sepsis-InducedOrgan Dysfunction and Recovery.Springer Berlin Heidelberg,2007:415-435.

共引文献10

同被引文献28

  • 1韩军花,杨月欣.转基因食品中的天然毒素与抗营养素[J].中国食品学报,2005,5(1):79-85. 被引量:6
  • 2程超,明庆磊.3种不同科属鱼血液流变学性质的比较研究[J].安徽农业科学,2005,33(4):659-660. 被引量:1
  • 3Expert Dyslipidemia Panel of the International Atherosclerosis So- ciety. An international atherosclerosis society position paper: Global recommendations for the management of dyslipidemia-full report. J Clin Lipidol, 2014, 8: 29-60.
  • 4Bays HE, Jones PH, Brown VW, et al. National lipid associa- tion annual summary of clinical lipidology 2015. J Clin Lipidol, 2014, 8 : S1-$36.
  • 5Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS guide- lines for the management of dyslipidaemias. Eur Heart J, 2011, 32: 1769-1818.
  • 6Ridker PM. LDL cholesterol : controversies and future therapeutic directions. Lancet, 2014, 384: 607-17.
  • 7Ruiz-Canela M, Toledo E, Clish CB, et al. Plasma branched- chain amino acids and incident cardiovascular disease in the pre- dimed trial. Clin Chem, 2016, 62: 582-592.
  • 8Nestel P, Clifton P, Colquhoun D, et al. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treat- ment of cardiovascular disease. Heart Lung Circ, 2015, 24: 769 -779.
  • 9Cahill LE, Bertoia ML, Aroner SA, et al. New and emerging bi- omarkers in cardiovascular disease. Curr Diab Rep, 2015, 15: 88-102.
  • 10Liu WC, Wu CC, Hung YM, et al. Pleiotropic effects of vitamin D in chronic kidney diseas. Clin Chim Acta, 2016, 453: 1-12.

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部